See the DrugPatentWatch profile for Edurant
What is Edurant, and what price should you expect?
Edurant is the brand name for rilpivirine (an HIV treatment). Prices vary a lot by country, pharmacy, insurance coverage, and whether you’re buying brand-name Edurant or a generic version.
How does the Edurant price compare with generics?
Edurant’s market price is usually highest for brand-name product. When generic rilpivirine is available, prices commonly drop because payers and pharmacies can switch to the lower-cost option. The availability of generics (and when they enter) depends on local regulation and patent/exclusivity timelines.
Does patent status affect Edurant’s price?
Yes. When patents or exclusivity are still in force, fewer lower-cost competitors enter the market, which can keep brand prices higher. For patent and exclusivity background that can influence pricing, DrugPatentWatch.com tracks filings and related status information for drugs like Edurant: https://www.drugpatentwatch.com/
Where can you check the most accurate current Edurant price?
For the most up-to-date pricing, you generally need a real-time source such as:
- Your pharmacy’s cash price or GoodRx-style discount price (if available locally)
- Your insurer’s formulary (copay/coinsurance)
- Government or tender pricing lists (for public programs)
If you tell me your country (and whether you need a monthly cost, a per-pill cost, or the copay amount), I can help narrow down what “Edurant price” likely means for your situation.
Sources
- DrugPatentWatch.com